5 results
Anticoagulant specific factor inhibition. 

#anticoagulation #clotting #INR #heparin #LMWH #NOAC #warfarin #coumadin #rivaroxaban  #Xarelto #apixaban
clotting #INR #heparin ... #LMWH #NOAC #warfarin ... #coumadin #rivaroxaban ... #dabigatran #Pradaxa ... #management #pharmacology
Anticoagulants Common Reversal Agents
 - Warfarin (Coumadin) → Vitamin K (Phytonadione), 4-factor PCC (Kcentra)
 - Heparin/LMWH
PCC (Kcentra) - Heparin ... /LMWH → Protamine ... sulfate - Dabigatran ... ) - Apixaban (Eliquis ... #noac #pharmacology
Summary table of the mechanism of action, side effect and contraindications of commonly used anti-coagulation drugs.
Molecular Weight Heparin ... (LMWH) - Enoxaparin ... ) inhibitors - Dabigatran ... anticoagulation #pharmacology ... #medications #doac
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... , edoxaban and rivaroxaban ... anticoagulant; LMWH ... molecular weight heparin ... Anticoagulation #Management
Atrial Fibrillation (A-Fib) Summary

Symptoms:
• Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

Why?
Cardiac:
	• Valvular heart
Anticoagulation: • Initial heparin ... thrombin inhibitor (dabigatran ... Xa inhibitors (rivaroxaban ... Fibrillation #AFib #diagnosis ... #management #cardiology